Title:
XANTHINE DERIVATIVE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2021/109970
Kind Code:
A1
Abstract:
Disclosed is a xanthine derivative pharmaceutical composition, specifically, a xanthine derivative pharmaceutical composition, a preparation method therefor, and the use thereof as a therapeutic drug, especially as a therapeutic dipeptidyl peptidase (DPP-IV) inhibitor.
More Like This:
| JP3117823 | COLLAGEN METABOLISM ACTIVATOR |
| JP2023510274 | Use of FXR agonists to treat infection with hepatitis D virus |
| JPS6051112 | ANTIVIRAL BLENDED COMPOSITION |
Inventors:
LIU XIUZHI (CN)
CHEN YAN (CN)
LI ZHANGCAI (CN)
WANG YING (CN)
CHEN YAN (CN)
LI ZHANGCAI (CN)
WANG YING (CN)
Application Number:
PCT/CN2020/132825
Publication Date:
June 10, 2021
Filing Date:
November 30, 2020
Export Citation:
Assignee:
CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
A61K31/522; A61P3/10; C07D473/04
Foreign References:
| CN103509023A | 2014-01-15 | |||
| CN101437493A | 2009-05-20 | |||
| CN104292228A | 2015-01-21 | |||
| CN1675212A | 2005-09-28 | |||
| CN103936737A | 2014-07-23 | |||
| CN103936738A | 2014-07-23 |
Other References:
ALI ZULPHIKAR, AKHTAR MD J., SIDDIQUI ANEES A., KHAN AHSAN A., HAIDER MD R., YAR MOHAMMAD S.: "Design, Synthesis, and Biological Evaluation of Novel Quinazoline Clubbed Thiazoline Derivatives : Novel Quinazoline Clubbed Thiazoline Derivatives", ARCHIV DER PHARMAZIE, WILEY VERLAG, WEINHEIM, vol. 350, no. 2, 1 February 2017 (2017-02-01), Weinheim, pages 1600298, XP055818808, ISSN: 0365-6233, DOI: 10.1002/ardp.201600298
Download PDF: